However, GFAP did not correlate with peripheral interleukin‐6 (IL‐6) or total antioxidant capacity (TAC), suggesting that peripheral and CNS inflammation may contribute to the pathophysiology of bipolar disorder in distinct ways. The gene discussed is GFAP; the disease is bipolar disorder.